Pharmacology of Reticulospinal vasomotor neurons in cardiovascular regulation

Pharmacological Reviews

Volumn 48, Issue 4, 1996, Pages 465-494

  Sun, Miao Kun ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 4 AMINOBUTYRIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ACETYLCHOLINE; ADENOSINE; ADENOSINE TRIPHOSPHATE; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; ALPHA ADRENERGIC RECEPTOR; ANESTHETIC AGENT; ANGIOTENSIN; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; CLONIDINE DISPLACING SUBSTANCE; ENDOTHELIN; EXCITATORY AMINO ACID RECEPTOR; GLUTAMATE RECEPTOR; GLYCINE; IMIDAZOLINE; IMIDAZOLINE RECEPTOR; IONOTROPIC RECEPTOR; LEVODOPA; METABOTROPIC RECEPTOR; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; OPIATE PEPTIDE; SEROTONIN; UNINDEXED DRUG; VASOPRESSIN;

ADRENERGIC NERVE; ARTERIAL PRESSURE; CARDIOVASCULAR AUTOREGULATION; CHOLINERGIC TRANSMISSION; HEART FAILURE; HUMAN; HYPERTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRACISTERNAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RETICULOSPINAL TRACT; REVIEW; SHOCK; SYMPATHETIC TONE;

ANIMALS; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; HUMANS; MOTOR NEURONS; SPINAL CORD; VASOMOTOR SYSTEM;

EID: 0030457307     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (408)

1. ABRAHAMS, T. P., HORNBY, P. J., CHEN, K., DASILVA, A. M. T., AND GILLIS, R. A.: The non-NMDA subtype of excitatory amino acid receptor plays the major role in control of cardiovascular function by the subretrofacial nucleus in cats. J. Pharmacol. Exp. Ther. 270: 424-432, 1994.
2. AGARWAL, S. K., AND CALARES U, F. R.: Interaction of putative neurotransmitters in rostral ventrolateral medullary cardiovascular neurons. J. Auton. Nerv. Syst. 38: 159-166, 1992.
3. AIYAR, N., BAKER, E., VICHERY-CLARK, L., OHLSTEIN, E. H., GELLAI, M., FREDRICKSON, T. A., BROOKS, D. P., WEINSTOCK, J., WEIDLEY, E. F., AND EDWARDS, R. M.: Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin AT1 antagonist. Eur. J. Pharmacol. 283: 63-72, 1995.
4. ALLEN, A. M., DAMPNEY, R. A. L., AND MENDELSOHN, F. A. O.: Angiotensin receptor binding and pressor effects in cat subretrofacial nucleus. Am. J. Physiol. 255: H1011-H1017, 1988.
5. 2-Adrenoceptor-mediated inhibition of bulbospinal barosensitive cells of rat rostral medulla. Am. J. Physiol. 265: R1065-R1075, 1993.
6. ALLY, A., HARA, Y., AND MURAYAMA, S.: Cardiovascular effects of central administration of cholino-mimetics in anesthetized cats. Neuropharmacology 32: 185-193, 1993.
7. AMANO, M., ASARI, T., AND KUBO, T.: Excitatory amino acid receptors in the rostral ventrolateral medulla mediate hypertension induced by carotid body chemoreceptor stimulation. Naunyn Schmiedebergs Arch. Pharmacol. 349: 549-554, 1994.
8. B receptors in tonic inhibitory control of blood pressure at the rostral ventrolateral medulla of the rat. Naunyn Schmiedebergs Arch. Pharmacol. 348:146-153, 1993.
9. ANDREATTA-VAN LEYEN, S., AVERILL, D. B., AND FERRARIO, C. M.: Cardiovascular actions of vasopressin at the ventrolateral medulla. Hypertension 15(suppl. I): 102-106, 1990.
10. ANDREZIK, J. A., CHAN-PALAY, V., AND PALAY, S. L.: The nucleus paragiganto-cellularis lateralis in the rat: conformation and cytology. Anat. Embryol. 161: 355-371, 1981.
11. ARNERIC, S. P., GIULIANO, R., ERNSBERGER, P., UNDERWOOD, M. D., AND REIS, D. J.: Synthesis, release and receptor binding of acetylcholine in the C1 area of the rostral ventrolateral medulla: contributions in regulating arterial pressure. Brain Res. 511: 98-112, 1990.
12. ATLAS, D., AND BURSTEIN, Y.: Isolation of an endogenous clonidine-displacing substance from rat brain. FEBS Lett. 170: 387-390, 1984a.
13. ATLAS, D., AND BURSTEIN, Y.: Isolation and partial purification of a clonidine-displacing endogenous brain substance. Eur. J. Biochem. 144: 287-293, 1984b.
14. BABBEDGE, R. C., BLAND-WARD, P. A., HART, S. L., AND MOORE, P. K.: Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br, J. Pharmacol. 110: 225-228, 1993.
15. BARABAN, S. C., STORNETTA, R. L., AND GUYENET, P. G.: Respiratory control of sympathetic nerve activity during naloxone-precipitated morphine withdrawal in rats. J. Pharmacol. Exp. Ther. 265: 89-95, 1993.
16. BARABAN, S. C., STORNETTA, R. L., AND GUYENET, P. G.: Effects of morphine and morphine withdrawal on adrenergic neurons of the rat rostral ventro-lateral medulla. Brain Res. 676: 245-257, 1995.
17. BARMAN, S. M., AND GEBBER, G. L.: Rostral ventrolateral medullary and medullary raphe neurons with activity correlated to the 10-Hz rhythm in sympathetic nerve discharge. J. Neurophysiol. 68: 1535-1547, 1992.
18. BARRACO, R. A., CAMPBELL, W. R., SCHOENER, E. P., SHEHIN, S. E., AND M. PARIZON.: Cardiovascular effects of microinjections of adenosine analogues into the fourth ventricle of rats. Brain Res. 242: 17-25, 1987.
19. BEILIN, L. J.: Alcohol, hypertension and cardiovascular disease. J. Hypertens. 13; 939-942, 1995.
20. BIRSE, E. F., EATON, S. A., JANE, D. E., JONES, P. L. J., POTTER, R. H. P., POOK, P. C. K., SUNTER, D. C., UDVARHELYI, P. M., WHARTON, B., ROBERTS, P. J., SALT, T. E., AND WATKINS, J. C.: Phenylglycine derivatives as new pharmacological tools for investigating the role of metabotropic glutamate receptors in the central nervous system. Neuroscience 52: 481-488, 1993.
21. BISHOP, V. S., RYUZAKI, M., CAI, Y., NISHIDA, Y., AND Cox, B. F.: Angiotensin II-dependent hypertension and the arterial baroreflex. Clin. Exp. Hypertens. 17: 29-38, 1995.
22. BOUSQUET, P.: Imidazoline receptors: from basic concepts to recent developments. J. Cardiovasc. Pharmacol. 26(suppl. 2): S1-S6, 1995.
23. BOUSQUET, P., FELDMAN, J., AND ATLAS, D.: An endogenous, non-catecholamine clonidine antagonist increases mean arterial blood pressure. Eur. J. Pharmacol. 124: 167-170, 1986.
24. BOUSQUET, P., FELDMAN, J., AND ATLAS, D.: Central cardiovascular effects of a non-catecholamine endo-genous ligand for clonidine receptors. J. Cardiovasc. Pharmacol. 10(suppl. 12): S167-S171, 1987.
25. BOUSQUET, P., FELDMAN, J., BLOCH, R., AND SCHWARTZ, J.: The nucleus reticularis lateralis, a region highly sensitive to clonidine. Eur. J. Pharmacol. 69: 389-392, 1981.
26. BOUSQUET, P., FELDMAN, J., AND SCHWARTZ, J.: Central cardiovascular effects of α-adrenergic drugs: difference between catecholamines and imidazolines. J. Pharmacol. Exp. Ther, 230: 232-236, 1984.
27. BREDT, D. S., HWANG, P. M., AND SNYDER, S. H.: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature (Lond.) 347: 768-770, 1990.
28. BREZENOFF, H. E., AND CAPUTI, A. P.: Intracerebroventricular injection of hemicholinium-3 lowers blood pressure in conscious spontaneously hypertensive rats but not in normotensive rats. Life Sci. 26: 1037-1045, 1980.
29. BREZENOFF, H. E., AND GIULIANO, R.: Cardiovascular control by cholinergic mechanisms in the central nervous system. Annu. Rev. Pharmacol. Toxicol. 22: 341-381, 1982.
30. BRICCA, G., M. DONTENWILL, A. MOLINES, J, FELDMAN, A. BELCOURT, AND BOUSQUET. P.: The imidazoline prefer-ring receptor: binding studies in bovine, rat and human brainstem. Eur. J. Pharmacol. 162: 1-9, 1989.
31. 3H]clonidine. Eur. J. Pharmacol. 268: 25-33, 1994.
32. 3H]-donidine to identify imidazoline receptors in the rabbit brainstem. Br. J. Pharmacol. 110: 1537-1543, 1993.
33. BROOKS, V. L., ELL, K. R., AND WRIGHT, R M.: Pressure-independent baroreflex resetting produced by chronic infusion of angiotensin II in rabbits. Am. J. Physiol. 265: H1275-H1282, 1993.
34. BUCCAFUSCO, J. J.: The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension. Pharmacol. Rev. 48: 179-211, 1996.
35. BUCCAFUSCO, J. J., AND BREZENOFF, H. E.: Pharmacological study of a cholinergic mechanism within the rat posterior hypothalamic nucleus which mediates a hypertensive response. Brain Res. 165: 295-310, 1979.
36. BUCCAFUSCO, J. J., AND SPECTOR, S.: Role of central cholinergic neurons in experimental hypertension. J. Cardiovasc. Pharmacol. 2: 347-355, 1980.
37. BYLUND, D. B.: Pharmacological characteristics of alpha-2 adrenergic receptor subtypes. Ann. N. Y. Acad. Sci. 763: 1-7, 1995.
38. CALVER, A., COLLIER, J., AND VALLANCE, P.: Nitric oxide and cardiovascular control. Exp. Physiol. 78: 303-326, 1993.
39. 2 sites. J. Pharmacol. Exp. Ther. 272: 681-688, 1995.
40. CHAN, C. K. S., SANNAJUST, F., AND HEAD, G. A.: Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. J. Pharmacol. Exp. Ther. 276: 411-420, 1996.
41. CHAN, R. K. W., CHAN, Y. S., AND WONG, T. M.: Cardiovascular responses to electrical stimulation of the ventrolateral medulla of the spontaneously hypertensive rat. Brain Res. 522: 99-106, 1990.
42. CHAN, R. K. W., CHAN, Y. S., AND WONG, T. M.: Responses of cardiovascular neurons in the rostral ventrolateral medulla of the normotensive Wistar Kyoto and spontaneously hypertensive rats to iontophoretic application of angiotensin II. Brain Res. 556: 145-150, 1991.
43. CHEN, P. Y., AND SANDERS, P. W,: L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 88: 1559-1567, 1991.
44. CHIU, A. T., CARINI, D. J., JOHNSON, A. L., MCCALL, D. E., PRICE, W. A., THOOLEN, M. J. M. C., WONG, P. C., TABER, R. I., AND TIMMERMANS, P. B. M. W. M.: Nonpeptide angiotenein II receptor antagonists. II. Pharmacology of S-8308. Eur. J. Pharmacol. 157: 13-21, 1988.
45. 2 agonists. Brain Res. 515: 299-302, 1990.
46. CLEMENT, M. E., AND MCCALL, R. B.: Effects of clonidine on sympathoexcitatory neurons in the rostral ventrolateral medulla. Brain Res. 550: 353-357, 1991.
47. COCHRANE, K. L., BUCHHOLZ, R. A., KEETON, T. K., AND NATHAN, M. A.: Hypotensive effects of lesions of the rostral ventrolateral medulla in rats ia anesthetic-dependent. J. Auton. Nerv. Syst. 22: 181-187, 1988.
48. COCHRANE, K. L., AND NATHAN, M. A.: Normotension in conscious rats after placement of bilateral electrolytic lesion in the rostral ventrolateral medulla. J. Auton. Nerv. Syst. 26: 199-211, 1989.
49. COCHRANE, K. L., AND NATHAN, M. A.: Cardiovascular effects of lesion of the rostral ventrolateral medulla and the nucleus reticularis parvocellularis in rats. J. Auton. Nerv. Syst. 43: 69-82, 1993a.
50. COCHRANE, K. L., AND NATHAN, M. A.: Pressor systems involved in the maintenance of arterial pressure after lesions of the rostral ventrolateral medulla. J. Auton. Nerv. Syst. 46: 9-18, 1993b.
51. COCHRANE, K. L., AND NATHAN, M. A.: Pressor system involved in the maintenance of arterial pressure after lesions of the rostral ventrolateral medulla. J. Auton. Nerv. Syst. 46: 9-18, 1994.
52. CORTES, R., PROBST, A., AND PALACIOS, J. M.: Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: brainstem. Neuroscience 12: 1003-1026, 1984.
53. Cox, B. F., AND BISHOP, V. S.: Neural and humoral mechanisms of angiotensin-dependent hypertension. Am. J. Physiol. 261: H1284-H1291, 1991.
54. CULL-CANDY, S. G., MATHIE, A., AND POWIS, D. A.: Acetylcholine receptor channels and their block by clonidine in cultured bovine chromaffin cells. J. Physiol. (Lond.) 402: 255-278, 1988.
55. CUNHA, R. S., CABRAL, A. M., AND VASQUEZ, E. C.: Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. Am. J. Hypertens. 6: 806-809, 1993.
56. CZYŹEWSKA-SZAFRAN, H., JASTREZEBSKI, Z., REMISZEWSKA, M., AND WUTKIEWICZ, M.: Effect of clonidine on blood pressure and GABAergic mechanism in spontaneously hypertensive rats. Eur. J. Pharmacol. 198: 115-120, 1991.
57. 1A receptor agonists on the ventro-lateral medullary pressor area in dogs. J. Cardiovasc. Pharmacol. 15(suppl. 7): S61-S67, 1990.
58. DAMPNEY, R. A. L.: Functional organization of central pathways regulating the cardiovascular system. Physiol. Rev. 74: 323-364, 1994a.
59. DAMPNEY, R. A. L.: The subretrofacial vasomotor nucleus: anatomical, chemical and pharmacological properties and role in cardiovascular regulation. Prog. Neurobiol. 42: 197-227, 1994b.
60. DAMPNEY, R. A. L., BLESSING, W. W., AND TAN, E.: Origin of tonic GABAergic inputs to vasopressor neurons in the subretrofacial nucleus of the rabbit. J. Auton. Nerv. Syst. 24: 227-239, 1988.
61. DAWSON, T. M., DAWSON, V. L., AND SNYDER, S. H.: A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann. Neurol. 32: 297-311, 1992.
62. DELLE, M., RICKSTEN, S., HAGGENDAL, J., OLSSON, K., SKARPHEDINSSON, J. O., AND THORÉN, P.: Regional changes in systemic nerve activity levels of catecholamines, renin and vasopressin during naloxone-precipitated: morphine withdrawal in rats. J. Pharmacol. Exp. Ther. 253: 646-654, 1990.
63. DE LUCA, L. A., FRNACI, C. R., SAAD, W. A., CAMARGO, L. A. A., AND ANTUNES-RODRIGUES, J.: Natriuretics induced by cholinergic stimulation of locus coeruleus in the rat. Physiol. Behav. 47: 605-610, 1990.
64. DEUCHARS, S. A., MORRISON, S. F., AND GILBEY, M. P.: Medullary-evoked EPSPs in neonatal rat sympathetic preganglionic neurones in vitro. J. Physiol. (Lond.) 487: 453-463, 1995.
65. DEUTCH, A. Y., HOLLIDAY, J., ROTH, R. H., CHUN, L. L. Y., AND HAWROT, E.: Immunohistochemical localization of a neuronal nicotinic acetylcholine receptor in mammalian brain. Proc. Natl. Acad. Sci. USA 84 :8697-8701, 1987.
66. DE WILDT, D. J., AND PORSIUS, A. J.: Central cardiovascular effects of physostigmine in the cat: possible cholinergic aspects of blood pressure regulation. Arch. Int. Pharmacodyn. Ther. 263: 22-29, 1981.
67. DIBONA, G. F., JONES, S. Y., AND BROOKS, V. L.: ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am. J. Physiol. 269: R1189-R1196, 1995.
68. DONI, M. G., WHITTLE, B. J., PALMER, R. M., AND MONCADA, S.: Actions of nitric oxide on the release of prostacylin from bovine endothelial cells in culture. Eur. J. Pharmacol. 151: 19-25, 1988.
69. DUN, N. J., DUN, S. L., AND CHIAIA, N. L.: Hemorrhage induces Foe immunoreactivity in rat medullary catecholaminergic neurons. Brain Res. 608: 223-232, 1993.
70. EATON, S. A., JANE, D. E., JONES, P. L. J., POTER, R. H. P., POOK, P. C. K., SUNDER, D. C., UDVARHELYI, P. M., ROBERTS, P. J., SALT, T. E., AND WATKINS, J. C.: Competitive antagonism at metabotropic glutamate receptors by (S)-4-carboxyphenylglycine and (RS)-α-methyl-4-carboxyphenyl-glycine. Eur. J. Pharmacol. 244: 195-197, 1993.
71. ECKENHOFF, R. C.: An inhalational anesthetic binding domain in the nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA 93: 2807-2810, 1996.
72. ELSKAY, R. L., LONG, R. T., AND PALKOVITS, M.: Localization of immunoreactive thyrotropin releasing hormone in the lower brainstem of the rat. Brain Res. 277: 169-162, 1983.
73. ERNSBERGER, P. R., ARANGO, V., AND REIS, D. J.: A high density of muscarinic receptors in the rostral ventro-lateral medulla of the rat is revealed by correction for autoradiographic efficiency. Neurosci. Lett, 85: 179-186, 1988a.
74. 2-adrenergic receptors in the rostral ventro-lateral medulla. Hypertension 6(suppl. 4): S554-S557, 1988b.
75. ERNSBERGER, P. R., GIULIANO, R., WILLETTE, R. N., AND REIS, D. J.: Role of imidazole receptors in the vaso-depressor response to clonidine analogs in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther. 253: 408-418, 1990.
76. 2-adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol. 134: 1-13, 1987.
77. ERNSBERGER, P. R., MEELEY, M. P., AND REIS, D. J.: An endogenous substance with clonidine like properties: selective binding to imidazole sites in the ventrolateral medulla. Brain Res. 441: 309-318, 1988c.
78. ESLER, M.: Sympathetic nervous system: contribution to human hypertension and related cardiovascular diseases. J. Cardiovasc. Pharmacol. 26(suppl. 2): S24-S28, 1995.
79. FELDMAN, J., TIBIRICA, E., BRICCA, G., DONTENWILL, M., BELCOURT, A., AND BOUSQUET, P.: Evidence from the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. Br. J. Pharmacol. 100: 600-604, 1990.
80. FERGUSON, D. W.: Sympathetic mechanisms in heart failure: pathophysiological and pharmacological implications. Circulation 87(suppl. VII): 68-75, 1993.
81. FISHER, L. A., KIKKAWA, D. O., RIVIER, J. E., AMARA, S. G., EVANS, R. M., ROSENFELD, M. G., VALE, J. W. W., AND BROWN, M. R.: Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide. Nature (Lond.) 305: 534-536, 1983.
82. FÖRSTERMANN, U., GORSKY, L. D., POLLOCK, J. S., SCHMIDT, H. H., HELLER, M., AND MURAD, F.: Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain. Biochem. Biophys. Res. Commun. 168: 727-732, 1990.
83. FOUTZ, A. S., BOUDINOT, E., AND DENAVIT-SAUBIÉ, M.: Central respiratory depression induced by acetyl-cholinesterase inhibition: involvement of anaesthesia. Eur. J. Pharmacol. 142: 207-213, 1987.
84. FRANKS, N. P., AND LIEB, W. R.: Molecular and cellular mechanisms of general anaesthesia. Nature (Lond.) 367: 607-614, 1994.
85. GAO, Y., GUMUSEL, B., KOVES, G., PRASAD, A., HAO, Q., HYMAN, A., AND LIPPTON, H.: Agmatine: a novel endogenous vasodilator substance. Life Sci. 67: PL83-PL86, 1995.
86. GARTHWAITE, J., CHARLES, S. L., AND CHESS-WILLIAMS, R.: Endothelium-derived relaxing factor release activation of NMDA receptor suggests role as intracellular messenger in the brain. Nature (Lond.) 336: 385-388, 1988.
87. GEBBER, G. L., BARMAN, S. M., AND ZVIMAN, M.: Sympathetic activity remains synchronized in presence of a glutamate antagonist. Am. J. Physiol. 256: R722-R732, 1989.
88. GIULIANO, R., AND BREZENOFF, H. E.: Increased central cholinergic activity in rat models of hypertension. J. Cardiovasc. Pharmacol. 10: 113-122, 1987.
89. GIULIANO, R., RUGGIERO, D. A., MORRISON, S., ERNSBERGER, P., AND REIS, D. J.: Cholinergic regulation of arterial pressure by the Cl area of the rostral ventrolateral medulla. J. Neurosci. 9: 923-942, 1989.
90. GOMEZ, R. E., ERNSBERGER, P., FEINLAND, G., AND REIS, D. J.: Rilmenidine lowers arterial pressure via imidazole receptors in brainstem Cl area. Eur. J. Pharmacol. 195: 181-191, 1991.
91. GOMEZ, R. E., CANNATA, M. A., MILNER, T. A., ANWAR, M., AND REIS, D. J.: Vasopressinergic mechanisms in the nucleus reticularis lateralis in blood pressure control Brain Res. 604: 90-105, 1993.
92. GOSHIMA, Y., KUBO, T., AND MISU, Y.: Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices. Br. J. Pharmacol. 89: 229-234, 1986.
93. GOSHIMA, Y., NAKAMURA, S., AND MISU, Y.: L-Dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices. J. Pharmacol. Exp. Ther. 258: 466-471, 1991.
94. 2+-dependent and tetrodotoxin-sensitive release of endogenous glutamate from rat striatal slices. Brain Res. 617: 167-170, 1993.
95. GOZLAN, H., DIABIRA, D., CHINESTRA, P., AND BEN-ARI, Y.: Anoxic LTP is mediated by the redox modulatory site of the NMDA receptor. J. Neurophysiol. 72: 3017-3022, 1994.
96. GRANATA, A. R., NUMAO, Y., KUMADA, M., AND REIS, D. J.: A1 noradrenergic neurons tonically inhibit sympathoexcitatory neurons of C1 area in rat brainstem. Brain Res. 377: 127-146, 1986.
97. GRANATA, A. R.: Rostral ventrolateral medulla descending neurons excited by nucleus tractus solitarii inputs. Brain Res. 648: 299-305, 1994.
98. 3H]-clonidine. Neurochem. Int. 25: 183-191, 1994a.
99. GRENEY, H., BENNAI, F., MOLINES, A., BELCOURT, A., DONTENWILL, M., AND BOUSQUET, P.: Isolation of a human cerebral imidazoline specific binding protein. Eur. J. Pharmacol. 265: R1-R2, 1994b.
100. GULATI, A., AND REBELLO, S.: Down-regulation of endothelin receptors in the ventrolateral medulla of spontaneously hypertensive rats. Life Sci. 48: 1207-1215, 1991.
101. GULATI, A., REBELLO, S., ROY, S., AND SAXENA, P. R.: Cardiovascular effects of centrally administered endothelin-1 in rats. J. Cardiovasc. Pharmacol. 26: S244-S246, 1995.
102. GUYENET, P. G.: Role of the ventral medulla oblongata in blood pressure regulation. In Central Regulation of Autonomic Functions, ed. by A. D. Loewy and K M. Spyer, pp. 145-167, Oxford University Press, New York, USA, 1990.
103. 2A-Adrenergic receptors are present in lower brainstem catecholaminegic and serotonergic neurons innervating spinal cord. Brain Res. 638: 285-294, 1994.
104. GUYTON, A. C.: Blood pressure control-special role of the kidneys and body fluids. Science (Wash. DC) 252: 1813-1816, 1991.
105. 1 receptor mRNA and angio-tensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul. Pept. 49: 167-174, 1993.
106. HAACK, D., AND MÖHRING, J.: Vasopressin mediated blood pressure response to intraventricular injection of angiotensin II in the rat. Pflugers Arch. 373: 167-173, 1978.
107. HACKENTHAL, E., PAUL, M., GANTEN, D., AND TAUGNER, R.: Morphology, physiology and molecular biology of renin secretion, Physiol. Rev. 70: 1067-1116, 1990.
108. HANSEN, J., JACOBSEN, T. N., AND VICTOR, R. G.: Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans? Hypertension 24: 439-444, 1994.
109. HARA, Y., ALLY, A., AND MURAYAMA, S.: Central cardiovascular effects of physostigmine in anesthetized cats. Neuropharmacology 31: 923-928, 1992.
110. HARADA, S., TOKUNAGA, S., MOMOHARA, M., MASAKI, H., TAGAWA, T., IMAIZUMI, T., AND TAKESHITA, A.: Inhibition of nitric oxide formation in the nucleus solitarius increases renal sympathetic nerve activity in rabbits. Circ. Res. 72: 511-516, 1993.
111. HARLAND, D., GARDINER, S. M., AND BENNETT, T.: Cardiovascular and dipsogenic effects of angiotensin II administered icv in Long-Evans and Brattleboro rats. Brain Res. 455: 58-64, 1988.
112. HARRISON, J. K., D'ANGELO, D. D., ZENG, D., AND LYNCH, K. R.: Pharmacological characterization of rat a2-adrenergic receptors. Mol. Pharmacol. 40: 407-411, 1991.
113. HARUTA, K., IGUCHI, A., MATSUBARA, T., ITOH, K., CHELANG, C., YOSHIDA, S., TERADA, R., KANASHIRO, M., SUZUKI, O., NISHIMURA, H., AND SAKAMOTO, N.: Stimulation of muscarinic cholinoceptive neurons in the hippocampus evokes a pressor response with bradycardia. Life Sci. 50: 427-433, 1992.
114. HASELTON, J. R., AND GUYENET, P. G.: Electrophysiological characterization of putative C1 adrenergic neurons in the rat. Neuroscience 30: 199-214, 1989.
115. HASELTON, J. R., AND GUYENET, P. G.: Ascending collaterals of medullary barosensitive neurons and Cl cells in rats. Am. J. Physiol. 258: R1051-R1063, 1990.
116. HEAD, G. A., GODWIN, S. J., AND SANNAJUST, F.: Differential receptors involved in the cardiovascular effects of clonidine and rilmenidine in conscious rabbits. J. Hypertens. 11(suppl. 5): S322-S323, 1993.
117. HEIN, L., BARSH, G. S., PRATT, R. E., DZAU, V. J., AND KOBILKA, B. K.: Behavioral and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature (Lond.) 377: 744-747, 1995.
118. HELKE, C. J., MCDONALD, C. H., AND PHILLIPS, E. T.: Hypotensive effects of 5-HT(1A) receptor activation-ventral medullary sites and mechanisms of action in the rat. J. Auton. Nerv. Syst. 42: 177-188, 1993.
119. 2-adrenoceptors. Br. J. Pharmacol. 110: 1635-1639, 1993.
120. HIROOKA, Y., HEAD, G. A., POTTS, P. D., GODWIN, S. J., BENDLE, R. D., AND DAMPNEY, A. L.: Medullary neurons activated by angiotensin II in the conscious rabbit. Hypertension 27: 287-296, 1996.
121. HÖKFELT, T., FUXE, K., JOHANSSON, O., JEFFCOATE, S., AND WHITTE, N.: Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunocytochemistry. Eur. J. Pharmacol. 34: 389-392, 1975.
122. HUANGFU, D., GOODWIN, W. B., AND GUYENET, P. G.: Sympathetic effect of tricyclic antidepressants: site and mechanism of action in anesthetized rats. Am. J. Physiol. 268: R1429-R1441, 1995.
123. IADECOLA, C., FARIS, P. L., HARTMAN, B. K., AND Xu, X.: Localization of NADPH diaphorase in neurons of the rostral ventral medulla: possible role of nitric oxide in central autonomic regulation and oxygen chemoreception. Brain Res. 603: 173-179, 1993.
124. ITO, M., OLIVERIO, M. I., MANNON, P. J., BEST, C. F., MAEDA, N., SMITHIES, O., AND COFFMAN, T. M.: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc. Natl. Acad. Sci. USA 92: 3521-3525, 1995.
125. IWASE, S., MATSUKAWA, T., ISHIHARA, S., TANAKA, A., TANABE, K., DANBABA, A., MATSUO, M., SUGIYAMA, Y., AND MANO, T.: Effect of oral ethanol intake on muscle sympathetic nerve activity and cardiovascular functions in humans. J. Auton. Nerv. Syst. 54: 206-214, 1995.
126. JANSEN, A. S. P., NGUYEN, X. V., KARPITSKIY, V., METTENLEITER, T. C., AND LOEWY, A. D.: Central command neurons of the sympathetic nervous system: basis of the fight-flight response. Science (Wash. DC) 270: 644-646, 1995.
127. JASTRZE(Combining ogonek sign)BSKI, Z., CZYZEWSKA-SZAFRAN, H., GÓZLINSKA, B. REMISZEWSKA, M., AND MAZUREK, A. P.: Clonidine hypotension in spontaneously hypertensive rats (SHR) depends on the functional state of GABAergic and glutamatergic systems. Neurosci. Lett. 184: 94-96, 1995.
128. JOHNSON, R. A., AND FREEMAN, R. H.: Sustained hypertension in the rat induced by chronic blockade of nitric oxide production. Am. J. Hypertens. 5: 919-922, 1992.
129. JONES, B. E., AND BEAUDET, A.: Distribution of acetylcholine and catecholamine neurons in the cat brainstem: a choline acetyltransferase and tyrosine hydroxylase immunohistochemical study. J. Comp. Neurol. 261: 15-32, 1987.
130. KANGRGA, I. M., AND LOEWY, A. D.: Whole-cell recordings from visualized C1 adrenergic bulbospinal neurons: ionic mechanisms underlying vasomotor tone. Brain Res. 870: 215-232, 1995.
131. KANNAN, H., TANAKA, Y., KUNITAKE, T., UETA, Y., HAYASHIDA, Y., AND YAMASHITA, H.: Activation of sympathetic outflow by recombinant human interleukin-1β in conscious rats. Am. J. Physiol. 270: R479-R485, 1996.
132. KARPPANEN, H., PAAKKARI, I., PAAKKARI P., HUOTARI, R., AND ORMA, A. L.: Possible involvement of central histamine H2-receptors in the hypotensive effect of clonidine. Nature (Lond.) 259: 587-588, 1976.
133. 2-adrenoceptor-mediated pressor response to clonidine in conscious, spontaneously hypertensive rats. Jpn. J. Pharmacol. 69: 321-331, 1992.
134. KIM, H.-S., KREGE, J. H., KLUCKMAN, K. D., HAGAMAN, J. H., HODGIN, J, B., BEST, C. F., JENNETTE, J. C., COFFMAN, T. M., MAEDA, N., AND SMITHIES, O.: Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. USA 92: 2735-2739, 1995.
135. 3H]nicotine binding in the human brainstem. Neuroscience 55: 1127-1138, 1993.
136. KLATT, P., SCHMID, M., LEOPOLD, E., SCHMID, K., WERNER, E. R., AND MAYER, B.: The pteridine binding site of brain nitric oxide synthese. Tetrahydropterin binding kinetics, specificity, and allosteric interaction with the substrate domain. J. Biol. Chem. 289: 13861-13866, 1994.
137. KOBINGER, W.: Central α-adrenergic systems as targets for hypotensive drugs. Rev. Physiol. Biochem. Pharmacol. 81: 40-100, 1978.
138. KOSEKI, C., IMAI, M., HIRATA, Y., YANAGISAWA, M., AND MASAM, T.: Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide? Am. J. Physiol. 256: R858-R866, 1989.
139. KOSHIYA, N., AND GUYENET, P. G.: Tonic sympathetic chemoreflex after blockade of respiratory rhythmogenesis in the rat. J. Physiol. (Lond.) 491: 859-869, 1996.
140. KOSHIYA, N., HUANGFU, D., AND GUYENET, P. G.: Ventrolateral medulla and sympathetic chemoreflex in the rat. Brain Res. 609: 174-184, 1993.
141. KREGE, J. H., JOHN, S. W. M., LANGEBACH, L. L., HODGIN, J. B., HAGAMAN, J. R., BACHMAN, E. S., JENNETTE, J. C., O'BRIEN, D. A., AND SMITHIES, O.: Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature (Lond.) 375: 146-148, 1995.
142. KRSMANOVIC, L. Z., STOJILKOVIC, S. S., BALLA, T., ALDAMLUJI, S., WEINER, R. I., AND CATT, K. J.: Receptor and neurosecretory actions of endothelin in hypothalamic neurons. Proc. Natl. Acad. Sci. USA 88: 11124-11128, 1991.
143. KRSTIC, M. K., AND DJURKOVIC, D.: Cardiovascular responses to injection of cholinomimetic drugs into the cerebral ventricles of unanesthetized dogs. Br. J. Pharmacol. 17: 341-347, 1973.
144. KUBO, T., AMANO, M., AND ASAHI, T.: N-Methyl-D-aspartate receptors but not non-N-methyl-D-aspartate receptors mediate hypertension induced by carotid body chemoreceptor stimulation in the rostral ventrolateral medulla of the rat. Neurosci. Lett. 164: 113-116, 1993.
145. KUBO, T., ISHIZUKA, T., FUKUMORI, R., ASARI, T., AND HAGIWARA, Y.: Enhanced release of acetylcholine in the rostral ventrolateral medulla of spontaneously hypertensive rats. Brain Res. 688: 1-9, 1995a.
146. KUBO, T., AND KIHARA, M.: Studies on GABAergic mechanisms responsible for cardiovascular regulation in the rostral ventrolateral medulla of the rat. Arch. Int. Pharmacodyn. Ther. 285: 277-287, 1987.
147. KUBO, T., NAGURA, J., KIHARA, M., AND MISU, Y.: Cardiovascular effects of L-glutamate and γ-aminobutyric acid injected into the rostral ventrolateral medulla in normotensive and spontaneously hypertensive rats. Arch. Int. Pharmacodyn. Ther. 279: 150-161, 1986.
148. KUBO, T., AND TATSUMI, M.: Increased pressor response to physostigmine in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch. Pharmacol. 308: 81-83, 1979.
149. KUBO, T., TAGUCHI, K., OZAKI, S., AMANO, M., AND ISHIZUKA, T.: 8-OH-DPAT-induced hypotensive action and sympathoexcitatory neurons in the rostral ventrolateral medulla of the rat. Brain Res. Bull. 36: 405-411, 1995b.
150. KUMAGAI, H., AVERILL, D. B., KHOSLA, M. C., AND FERRARIO, C. M.: Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats. Hypertension 21: 476-484, 1993.
151. KURIHARA, Y., KURIHARA, H., SUZUKI, H., KODAMA, T., MAEMURA, K., NAGAI, R., ODA, H., KUWAKI, T., CAO, W.-H., KAMADA, N., JISHAGE, K., OUCHI, Y., AZUMA, S., TOYODA, Y., ISHIKAWA, T., KUMADA, M., AND YAZAKI, Y.: Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature (Lond.) 368: 703-710, 1994.
152. KUSAMA, T., SPIVAK, C. E., DAWSON, V., SCHAEFFER, J. C., AND UHL, G.: Pharmacology of GABA pi and GABA α/β receptors expressed in Xenopus oocytes and COS cells. Br. J. Pharmacol. 109: 200-206, 1993.
153. KUWAKI , T., CAO, W.-H., UHEKAWA, M., TERUI, N., AND KUMADA, M.: Endothelin-sensitive areas in the ventral surface of the rat medulla. J. Auton. Nerv. Syst. 36: 149-158, 1991a.
154. KUWAKI, T., KOSHIYA, N., CAO, W. H., TAKAHASHI, H., TERUI, N., AND KUMADA, M.: Modulatory effects of endothelin-1 on central cardiovascular control in rats. Jpn. J. Physiol. 40: 827-841, 1990.
155. KUWAKI, T., KOSHIYA, N., TERUI, N., AND KUMADA, M.: Endothelin-1 modulates cardiorespiratory control by the central nervous system. Neurochem. Int. 18: 519-524, 1991b.
156. KUWAKI, T., KURIHARA, Y., KURIHARA, H., CAO, W.-H., UNEKAWA, M., LING, G.-Y., YAZAKI, Y., AND KUMADA, M.: Cardiorespiratory abnormalities in endothelin-1 gene knocked out mice (abstract). Can. J. Physiol. Pharmacol. 72: 106, 1994.
157. KUWAKI, T., KURIHARA, Y., KURIHARA, H., YAZAKI, Y., AND KUMADA, M.: Role of endothelin in central cardiorespiratory control: modern and classical approaches. News Physiol. Sci. 10: 228-233, 1995.
158. KUZNETSOV, V. I., AND GODUKHIN, O. V.: Mechanism of methionine-enkephalin modulation of glutamatergic transmission in the rat striatum. Neurosci. Lett. 57: 143-146, 1985.
159. LANDER, E. S., AND SCHORK, N. J.: Genetic dissection of complex traits. Science (Wash. DC) 256: 2037-2048, 1994.
160. LANGEMEIJER, J. J., DE WILDT, D. J., DE GROOT, G., AND SANGSTER, B.: Central origin of respiratory arrest in beta-blocker intoxication in rats. Toxicol. Appl. Pharmacol. 89: 399-407, 1987.
161. LEE, M. E., DE LA MONTE, S. M., No, S. C., BLOCH, K D., AND QUERTERMOUS, T.: Expression of the potent vasoconstrictor endothelin in the human central nervous system. J. Clin. Invest. 86: 141-147, 1990.
162. LEE, S. B., KIM, S. Y., AND SUNG, K W.: Cardiovascular regulation by cholinergic mechanisms in rostral ventrolateral medulla of spontaneously hypertensive rats. Eur. J. Pharmacol. 205: 117-123, 1991.
163. LEI, S. Z., PAN, Z. H. AGGARWAL, S. K., CHEN, H. S., HARTMAN, J., SUCHER, N. J., AND LIPTON, S. A.: Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 356: 768-774, 1992.
164. LI, G., REGUNATHAN, S., BARROW, C. J., ESHRAGHI, J., COOPER, R., AND REIS, D. J.: Agmatine: an endogenous clonidine-displacing substance in the brain. Science (Wash. DC) 263: 966-969, 1994.
165. A receptor subunit mRNA expression in hippocampus following transient cerebral ischemia in the gerbil. Hippocampus 3: 527-538, 1993.
166. LI, J.- S., LARIVIÈRE, R., AND SCHIFFRIN, E. L.: Effect of a nonselective endothelin antagonist on vascular remodeling in DOCA-salt hypertensive rats: evidence for a role of endothelin in vascular hypertrophy. Hypertension 24: 183-188, 1994.
167. LI, J.-S., AND SCHIFFRIN, E. L.: Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 25: 495-500, 1995.
168. LI, Y.-W., AND GUYENET, P. G.: Neuronal inhibition by a GABAB receptor agonist in the rostral ventro-lateral medulla of the rat. Am. J. Physiol. 268: R428-R437, 1995a.
169. LI, Y.-W., AND GUYENET, P. G.: Neuronal excitation by angiotensin II in the rostral ventrolateral medulla of the rat in vitro. Am. J. Physiol. 268: R272-R277, 1995b.
170. + conductance in rat bulbospinal neurons of the Cl area. Circ. Res. 78: 274-282, 1996.
171. 2-adrenergic receptors. Am. J. Physiol. 269: R1356-R1369, 1995.
172. LI, Y.-W., POLSON, J. W., AND DAMPNEY, R. A. L.: Angiotenein II excites vasomotor neurons but not respiratory neurons in the rostral and caudal ventrolateral medulla. Brain Res. 577: 161-164, 1992.
173. LIN, J. C., TSAO, W. L., AND WANG, Y.: Cardiovascular effects of NMDA in the RVLM of spontaneously hypertensive rats. Brain Res. Bull. 37: 289-294, 1995.
174. 2-adrenergic receptor subtypes b and c. Science (Wash. DC) 273: 803-805, 1996.
175. LIPSKI, J., KAHJHAN, R., KRUSZEWSKI, B., AND SMITH, M.: Barosensitive neurons in the rostral ventrolateral medulla of the rat in vivo: morphological properties and relationship to C1 adrenergic neurons. Neuroscience 69: 601-618, 1995.
176. LIPSKI, J., KANJHAN, R., KRUSZEWSKA, B., AND RONG, W.: Properties of presympathetic neurones in the rostral ventrolateral medulla in the rat: an intracellular study 'in vivo.' J. Physiol. (Lond.) 490: 729-744, 1996.
177. LIPTON, S. A.: Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16: 527-532, 1993.
178. LIPTON, S. A., AND STAMLER, J. S.: Actions of redox-related congeners of nitric oxide at the NMDA receptor. Neuropharmacology 33: 1229-1233, 1994.
179. LIPTON, S. A., CHOI, T. B., PAN, Z. H., LEI, S. Z., CHEN, H. S., SUCHER, N. J., LOSCALZO, J., SINGEL, D. J., STAMLER, J. S,: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds, Nature (Lond.) 364: 626-632, 1993.
180. LIPTON, S. A., CHOI, Y.-B., SUCHER, N. J., AND PAN, Z.-H.: Redox state, NMDA receptors and NO-related species. Trends Pharmacol. Sci. 17: 186-187, 1996.
181. LLEWELLYN-SMITH, I. J., MINSON, J. B., PILOWSKY, P. M., ARNOLD, L. F., AND CHALMERS, J. P.: The one hundred percent hypothesis: glutamate or GABA in synapses on sympathetic preganglionic neurons. Clin. Exp. Hypertens. 17: 323-333, 1995.
182. LLOYD, H. G. E., LINDSTRÖM, K., AND FREDHOLM, B. B.: Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem. Int. 23: 173-185, 1993.
183. ŁOŃ, S., SZAZEPAŃSKA-SADOWSKA, E., AND SZCZYPACZEWSKA, M.: Evidence that centrally released arginine vasopressin is involved in central pressor action of angiotensin II. Am. J. Physiol. 270: H167-H173, 1996.
184. LORING, R. H.: Agmatine acts as antagonist of neuronal nicotinic receptors. Br. J. Pharmacol. 98: 207-211, 1990.
185. LOVICK, T. A.: Cardiovascular responses to 5-HT in the ventrolateral medulla of the rat. J. Auton. Nerv. Syst 28: 35-41, 1989.
186. LUDBROOK, J., AND RUTTER, P. C.: Effect of naloxone on haemodynamic responses to acute blood loss in unanaesthetized rabbits. J. Physiol. (Lond.) 400: 1-14, 1988.
187. LYDIC, R., AND BAGHDOYAN, H. A.: Cholinoceptive pontine reticular mechanisms cause state-dependent respiratory changes in the cat. Neurosci. Lett. 10: 211-216, 1989.
188. 2a-adrenergic receptor subtype. Science (Wash. DC) 273: 801-803, 1996.
189. 14C]2-deoxyglucose autography. J. Cardiovaac. Pharmacol. 26(suppl. 2): S55-S58, 1995.
190. MAKARI, N. F., TRIMARCHI, G. R., AND BUCCAFUSCO, J. J.: Contribution of preand post-synaptic components to heightened central cholinergic activity in spontaneously hypertensive rats. Neuropharmacology 28: 379-386, 1989.
191. MANDAL, A. K., KELLAR, K. J., NORMAN, W. P., AND GILLIS, R. A.: Stimulation of serotonin2 receptors in the ventrolateral medulla of the cat results in nonuniform increases in sympathetic outflow. Circ. Res. 67: 1267-1280, 1990.
192. MANNING, R. D. J., HU., L., MIZELLE, H. L., MONTANI, J. P., AND NORTON, M. W.: Cardiovascular responses to long-term blockade of nitric oxide synthase. Hypertension 22: 40-48, 1993.
193. MANOLIS, A. J., OLYMPIOS, C., SIFAKI, M., HANDANIS, S., BRESNAHAN, M., GAVRAS, I., AND GAVRAS, H.: Suppressing sympathetic activation in congestive heart failure: a new therapeutic strategy. Hypertension 26: 719-724, 1995.
194. MAO, L.-M., AND ABDEL-RAHMAN, A. A.: Blockade of L-glutamate receptors in the rostral ventrolateral medulla contributes to ethanol-evoked impairment of baroreflexes in conscious rats. Brain Res. Bull. 37: 513-521, 1995.
195. MARMO, E., FILIPPELLI, W., MANAZZO, R., Russo, S., CAZZOLA, M., VACCA, C., AND ROSSI, F.: Participation of GABAergic mechanisms in the hypotensive and bradycardiac effects of clonidine: experimental study in conscious normotensive and hypertensive rats. Neuropharmacology 26: 1525-1528, 1987.
196. 2-autoreceptors. Eur. J. Pharmacol. 157: 23-29, 1988.
197. MCCALL, R. B.: GABA-mediated inhibition of sympathoexcitatory neurons by midline medullary stimulation. Am. J. Pharmacol. 255: R605-R615, 1988.
198. MCDONALD, J. W., FIX, A. S., TIZZANO, J. P., AND SCHOEPP, D. D.: Seizures and brain injury in neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist. J. Neurosci. 13: 4445-4455, 1993.
199. MCMILLAN, K., AND MASTERS, B. S. S.: Optical difference spectrophotometry as a probe of rat brain nitric oxide synthase heme-substrate interaction. Biochemistry 32: 9875-9880, 1993.
200. MEELEY, M. P., ERNSBERGER, P. R., GRANATA, A. R., AND REIS, D. J.: An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla. Life Sci. 38: 1119-1126, 1986.
201. MENDELSOHN, F. A. O., ALLEN, A. M., CLEVERS, J., DENTON, D. A., TARJAN, E., AND MCKINLEY, M. J.: Localization of angiotensin II receptor binding in rabbit brain by in vitro autoradiography. J. Comp. Neurol. 270: 372-384, 1988.
202. MICHEL, M. C., AND INSEL, P. A.: Are there multiple imidazoline binding sites? Trends Pharmacol. Sci. 10; 342-344, 1989.
203. MICHEL, M. C., AND ERNSBERGER, P.: Keeping an eye on the I site: imidazolinepreferring receptors. Trends Pharmacol. Sci. 13: 369-370, 1992.
204. MIEHE, U., LERANTH, C. OHM, T. G., AND NITSCH, R.: Long-lasting transneuronal dendritic changes of GABAergic neurons in the monkey dentate gyrus following entorhinal cortex lesion. Neurosci. Lett. 168: 115-118, 1994.
205. MILNER, T. A., PICKEL, V. M., ABATE, C., JOH, T, H., AND REIS, D. J.: Ultrastructural characterization of substance P-like immunoreactive neurons in the rostral ventrolateral medulla in relation to neurons containing catecholamine-synthesizing enzymes. J. Comp. Neurol. 270: 427-445, 1988.
206. MILNER, T. A., PICKEL, V. M., GIULIANO, R., AND REIS, D. J.: Ultrastructural localization of choline acetyltransferase in the rat rostral ventrolateral medulla: evidence for major synaptic relations with non-catecholaminergic neurons. Brain Res. 500: 67-89, 1989a.
207. MILNER, T. A., PICKEL, V. M., AND REIS, D. J.: Ultrastructural basis for interactions between central opioids and catecholamines. I. Rostral ventrolateral medulla. J. Neurosci. 9: 2114-2130, 1989b.
208. MISU, Y., AND GOSHIMA, Y.: Is L-dopa an endogenous neurotransmitter? Trends Pharmacol. Sci. 14: 119-123, 1993.
209. MISU, Y., GOSHIMA, Y., AND KUBO, T.: Biphasic actions of L-DOPA on the release of endogenous dopamine via presynaptic receptors in rat striatal slices. Neurosci. Lett. 72: 194-198, 1986.
210. MISU, Y., YUE, J.-L., AND GOSHIMA, Y.: L-DOPA systems for blood pressure regulation in the lower brainstem. Neurosci. Res. 23: 147-158, 1995.
211. MIURA, M., TAKAYAMA, K., AND OKADA, J.: Difference in sensitivity of cardiovascular and respiratory control neurons in the subretrofacial nucleus to glutamate receptor subtype agonists in SHR, WKY and cats. J. Auton. Nerv. Syst. 36: 1-12, 1991.
212. MIURA, M., TAKAYAMA, K., AND OKADA, J.: Distribution of glutamate- and GABA-immunoreactive neurons projecting to the cardioacceleratory center of intermediolateral nucleus of the thoracic cord of SHR and WKY rats: a double labeling study. Brain Res. 638: 139-150, 1994.
213. MIZOBE, T., AND OKUDA, C.: Changes in brain thyrotropin-releasing hormone in reversible and irreversible hemorrhagic shock in the rat. Circ. Shock 26: 245-256, 1988.
214. MONTAGUE, P. R., GANCAYCO, C. D., WINN, M. J., MARCHASE, R. B., AND FRIEDLANDER, M. J.: Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science (Wash. DC) 263: 973-977, 1994.
215. MOORE, P. K., WALLACE, P. GAFFEN, Z., HART, S. L., AND BABBEDGE, R. C.: Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br. J. Pharmacol. 110: 219-224, 1993a.
216. MOORE, P. K., BABBEDGE, R. C., WALLACE, P., GAFFEN, Z. A., AND HART, S. L.: 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits antinociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108: 296-297, 1993b.
217. MORIGUCHI, A., TALLANT, E. A., MATSUMURA, K., REILLY, T. M., WALTON, H., GANTEN, D., AND FERRARIO, C. M.: Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension 25: 1260-1265, 1995.
218. MORILAK, D. A., DROLET, G., AND CHALMERS, J.: Cardiovascular effects of opioid antagonist naloxone in rostral ventrolateral medulla of rabbits. Am. J. Physiol. 258: R325-R331, 1990.
219. MORILAK, D. A., SOMOGYI, P., MCILHINNEY, R. A. J., AND CHALMERS, J.: An enkephalin-containing pathway from nucleus tractus solitarius to the pressor area of the rostral ventrolateral medulla of the rabbit. Neuroscience 31: 187-194, 1989.
220. MORIN-SYRUN, M. P., CHAMPAGNAT, J., DENAVIT-SAUBIÉ, M., AND MOYANOVA, S.: The effects of acetylcholine on bulbar respiratory related neurones: consequences of anaesthesia by pentobarbital. Naunyn Schmiedebergs Arch. Pharmacol. 325: 205-208, 1984.
221. MORTON, J. J., BEATTIE, E. C., SPEIRS, A., AND GULLIVER, F.: Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. J. Hypertens. 11: 1083-1088, 1993.
222. MORRISON, S. F., CALLAWAY, J., MILNER, T. A., AND REIS, D. J.: Rostral ventrolateral medulla: a source of the glutamatergic innervation of the sympathetic intermediolateral nucleus. Brain Res. 562: 126-135, 1991.
223. MORRISON, S. F., MILNER, T. A., AND REIS, D. J.: Reticulospinal vasomotor neurons of the rat rostral ventrolateral medulla: relationship to sympathetic nerve activity and the Cl adrenergic cell group. J. Neurosci. 8: 1286-1301, 1988.
224. MOSQUEDA-GARCIA, R., INAGAMI, T., APPALSAMY, M., SUGIURA, M., AND ROBERTSON, M.: Endothelin as a neuropeptide: cardiovascular effects in the brainstem of normotensive rats. Circ. Res. 72: 20-35, 1993.
225. MOSQUEDA-GARCIA, R., YATES, K., O'LEARY, J., AND INAGAMI, T.: Cardiovascular and respiratory effects of endothelin in the ventrolateral medulla of the normotensive rat. Hypertension 26: 263-271, 1995.
226. A receptors by cAMP-dependent protein phosphorylation. Science (Wash. DC) 257: 661-665, 1992.
227. MURATANI, H., AVERILL, D. B., AND FERRARIO, C. M.: Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats. Am. J. Physiol. 260: R977-R984, 1991.
228. MURATANI, H., FERRARIO, C. M., AND AVERILL, D. B.: Ventrolateral medulla in spontaneously hypertensive rats: role of angiotensin II. Am. J. Physiol. 264: R388-R395, 1993.
229. NATTI, E. E., AND L. I., A.: Ventral medulla sites of muscarinic receptor subtypes involved in cardiorespiratory control. J. Appl. Physiol. 69: 33-41, 1990.
230. NICHOLAS, A. P., AND HANCOCK, M. B.: Immunocytochemical evidence for substance P and serotonin input to medullary bulbospinal adrenergic neurons. Neuroscience 27: 569-576, 1988.
231. NILAVER, G., ZIMMERMAN, E. A., WILKINS, J., MICHAELS, J., HOFFMAN, D., AND SILVERMAN, A.-J.: Magnocellular hypothalamic projections to the lower brain stem and spinal cord of the rat. Neuroendocrinology 30: 150-158, 1980.
232. 2-adrenoceptor mechanism in rabbits. Am. J. Physiol. 269: R1009-R1016, 1995.
233. NOSJEAN, A., AND GUYENET, P. G.: Role of ventrolateral medulla in sympatholytic effect of 8-OHDPAT in rats. Am. J. Physiol. 260: R600-R609, 1991.
234. OHTA, H., WATANABE, S., AND UEKI, S.: Cardiovascular changes induced by chemical stimulation of the amygdala in rats. Brain Res. Bull. 26: 575-581, 1991.
235. OKTAY, S(Combining ogonek sign)., ILHAN, M., ONUR, R., AND KAYAALP, S. O.: Antagonism of the hypertensive effect of physostigmine in anesthetized rat by morphine. Arch. Int. Pharmacodyn. Ther. 271: 275-281, 1984.
236. 2+-dependent and tetrodotoxin-sensitive release of endogenous glutamate from striata of conscious rats. Jpn. J. Pharmacol. 67(suppl. I): 233p, 1995.
237. 3H]-idazoxan binding sites in the rat brain. Br. J. Pharmacol. 108: 597-603, 1993.
238. ORER, H. S., ZHONG, S., BARMAN, S. A., AND GEBBER, G. L.: Central catecholaminergic neurons are involved in expression of the 10-Hz rhythm in SND. Am. J. Physiol. 270: R333-R341, 1996.
239. OSBORN, J. W., TAYLOR, R. F., AND SCHRAMM, L. P.: Determinants of arterial pressure after chronic spinal transection in rats. Am. J. Physiol. 256: R666-R673, 1989.
240. ÖZKUTLU, U., COS(Combining ogonek sign)KUN, T., ONAT, F., YEǦEN, B.C(Combining ogonek sign)., AND OKTAY, S(Combining ogonek sign).: Cardiovascular effects of centrally active cholinomimetics in conscious and anesthetized rats: the role of amygdala. Brain Res. Bull. 37: 569-573, 1995.
241. 2 cholinoceptors involved in cholinergic hypertension. Eur. J. Pharmacol. 250: 349-354, 1993.
242. PALMER, A. J., FLETCHER, A. E., BULPITT, C. J., BEEVERS, D. G., COLES, E. C., LEDINGHAMS, J. G. G., PETRIE, J. C., WEBSTER, J., AND DOLLERY, C. T.: Alcohol intake and cardiovascular mortality in hypertensive patients: report from the Department of Health Hypertension Care Computing Project. J. Hypertens. 12: 957-964, 1995.
243. 2-adrenergic receptor. J. Biol. Chem. 264: 11874-11878, 1989.
244. PERSSON, P. B.: Modulation of cardiovascular control mechanisms and their interaction. Physiol. Rev. 76: 193-244, 1996.
245. 2-adrenergic receptors. J. Pharmacol. Exp. Ther. 272: 581-587, 1995.
246. 2-adrenoceptor binding sites. Br. J. Pharmacol. 115: 689-695, 1995a.
247. 2-adrenoceptors. Naunyn-Schmiedebergs Arch. Pharmacol. 351: 10-16, 1995b.
248. PITTALUGA, A., AND RAITERI, M.: Clonidine enhances the release of endogenous γ-aminobutyric acid through alpha-2 and alpha-1 presynaptic adrenoceptors differentially located in rat cerebral cortex subrogions. J. Pharmacol. Exp. Ther. 245: 682-686, 1988.
249. PITTALUGA, A., TORELLI, R., AND RAITERI, M.: Clonidine differentially modulates the release of endogenous GABA in various brain areas. Pharmacol. Res. 24: 189-196, 1991.
250. 2-Adrenoceptors do not regulate catecholamine secretion by bovine adrenal medullary cells: a study with clonidine. Mol. Pharmacol. 29: 134-141, 1986.
251. PRIVITERA, P. J., GRANATA, A. R., UNDERWOOD, M. D., GAFFNEY, T. E., AND REIS, D. J.: C1-area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol. J. Pharmacol. Exp. Ther. 246: 529-533, 1988.
252. PRIVITERA, P. J., THIBODEAUX, H., AND YATES, P.: Rostral ventrolateral medulla as a site for the central hypertensive action of kinins. Hypertension 23: 52-58, 1994.
253. PRIVITERA, P. J., AND YATES, P.: Hypertensive effect of tissue kallikrein in rostral ventrolateral medulla is mediated by brain kinins. Brain Res. 704: 103-106, 1995.
254. PUNNEN, S., AND SAPRU, H. N.: Cardiovascular response to medullary microinjections of opiate agonists in urethane-anesthetized rats. J. Cardiovasc. Pharmacol. 8: 950-956, 1986.
255. PUNNEN, S., URBANSKI, R., KRIEGER, A. J., AND SAPRU, H. N.: Ventrolateral medullary pressor area: site of hypotensive action of clonidine. Brain Res. 422: 336-346, 1987.
256. PUNNEN, S., WILLETTE, R., KRIEGER, A.J., AND SAPRU, H.N.: Cardiovascular response to injections of enkephalin in the pressor area of the ventrolateral medulla. Neuropharmacology 23: 939-946, 1984.
257. PUNNEN, S., WILLETTE, R. N., KRIEGER, A. J., AND SAPRU, M.N.: Medullary pressor area: site of action of intravenous physostigmine. Brain Res. 382: 178-184, 1986.
258. QIAN, H.-H., AND DOWLING, J. E.: Pharmacology of novel GABA receptors found on rod horizontal cells of the white perch retina. J. Neurosci. 14: 4299-4307, 1994.
259. C receptors on hybrid bass retinal bipolar cells. J. Neurophysiol. 74: 1920-1928, 1995.
260. RASMUSSEN, K., AND AGHAJANIAN, G. K: Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rat: attenuation by lesions of the nucleus paragigantocellularis. Brain Res. 505: 346-350, 1989.
261. REGUNATHAN, S., MEELEY, M. P., AND REIS, D. J.: Expression of nonadrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medulla. Biochem. Pharmacol. 45: 1667-1765, 1993.
262. REGUNATHAN, S., AND REIS, D. J.: Imidazoline receptors and their endogenous ligands. Ann. Rev. Pharmacol. Toxicol, 36: 511-544, 1996.
263. REIS, D. J., GOLANOV, E. V., RUGGIERO, D. A., AND SUN, M.-K.: Sympathoexcitatory neurons of the rostral ventrolateral medulla are oxygen sensors and essential elements in the tonic and reflex control of the systemic and cerebral circulation. J. Hypertens. 12(Suppl. 10): S159-S180, 1994.
264. REIS, D. J., REGUNATHAN, S., AND MEELEY, M. P.: Imidazole receptor and clonidine-displacing substance in relationship to control of blood pressure, neuroprotection and adrenomedullary secretion. Am. J. Hypertens. 5: 51S-57S, 1992.
265. REMISZEWSKA, M., JASTRZEBSKI, Z., AND CZYZEWSKI-SZAFRAN, H.: Increased activity of the GABAergic system in selected brain areas after chronic propranolol treatment in spontaneously hypertensive rats. Biochem. Pharmacol. 44: 465-470, 1992.
266. RIBEIRO, M. O., ANTUNES, E., DE. NUCCI, G., LOVISOLO, S. M., AND ZATZ, R.: Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20: 298-303, 1992.
267. ROMIJIN, H. J., RUIJTER, J. M., AND WOLTERS, P. S.: Hypoxia preferentially destroys GABAergic neurons in developing rat neocortex explants in culture. Exp. Neurol. 100: 332-340, 1988.
268. ROMIJIN, H. J., JANSZEN, A. W. J. W., VAN VOORST, M. J. D., BUIJS, R. M., BALAZS, R., AND SWAAB, D. F.: Perinatal hypoxic ischemic encephalopathy affects the proportion of GABA-immunoreactive neurons in the cerebral cortex of the rat. Brain Res. 692: 17-28, 1992.
269. 2A-adrenergic receptors in catecholaminergic and other brainetem neurons in the rat. Neuroscience 56: 139-155, 1993.
270. Ross, C. A., RUGGIERO, D. A., JOH, T. H., PARK, D. H., AND REIS, D. J.: Rostral ventrolateral medulla: selective projections to the thoracic spinal cord. J. Comp. Neurol. 228: 168-185, 1984a.
271. ROSS, C. A., RUGGIERO, D. A., PARK, D. H., JOH, T. H., SVED, A. F., FERNANDEZ-PARDAL, J., SAAVEDRA, J. M., AND REIS, D. J.: Tonic vasomotor control by the rostral ventrolateral medulla: effect of electrical or chemical stimulation of the area containing Cl adrenaline neurons on arterial pressure, heart rate, and plasma catecholamines and vasopressin. J. Neurosci. 4: 474-494, 1984b.
272. 2-adrenoceptor subtypes. Annu. Rev. Pharmacol. Toxicol. 33: 243-279, 1993.
273. RUGGIERO, D. A., CRAVO, S. L., ARANGO, V., AND REIS, D. J.: Central control of the circulation by the rostral ventrolateral reticular nucleus: anatomical substrate. In: Central Neural Organization of Cardiovascular Control, ed. by J. Ciriello, M. M. Caverson, and C. Polosa, Progress in Brain Research (series), vol. 81, pp. 49-79, Elsevier, Amsterdam, 1989.
274. RUMSEY, W. L., PATEL, B., KUCZYNSKI, B., NARRA, R. K., CHAN, Y.-W., LINDER, K. E., CYR, J., RAJU, N., RAMALINGAM, K., AND NUNN, A. D.: Potential of nitroimidazoles as markers of hypoxia in heart. Oxygen Transport to Tissue XV. Ed. by P. Vaupel, R. Zander, J. Gutenberg, and F. Bruley, pp. 263-269, Plenum Press, New York, USA, 1994.
275. SAEKI, Y., SATO, A., SATO, Y., AND TRZEBSKI, A.: Stimulation of the rostral ventrolateral medullary neurons increases cortical cerebral blood flow via activation of the intracerebral neural pathway. Neurosci. Lett. 107: 26-32, 1989.
276. G-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone. Circ Res. 70: 607-611, 1992.
277. SANDERS, K. M., AND WARD, S. M.: Nitric oxide as a mediator of nonadrenergic noncholinergic neuro-transmission. Am. J. Physiol. 262: G379-G392, 1992.
278. SANNAJUST, F., AND HEAD, G. A.: Rilmenidine-induced hypotension involves imidazoline-preferring receptors in conscious rabbits. J. Cardiovasc. Pharmacol. 23: 42-50, 1994.
279. SAPRU, H. N., PUNNEN, S., AND WILLETTE, R. N.: Role of enkephalins in ventrolateral medullary control of blood pressure. In: Brain Peptides and Catecholamines in Cardiovascular Regulation, ed. by J. P. Buckley, and C. M. Ferrario, pp. 153-167, Raven Press, New York, 1987.
280. SASAKI, S., AND DAMPNEY, R. A. L.: Tonic cardiovascular effects of angiotensin-II in the ventro-lateral medulla. Hypertension 15: 274-283, 1990.
281. SCHIFFRIN, E. L., SVENTEK, P., LI., J.-S., TURGEON, A., AND REUDELHUBER, T.: Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats. Br. J. Pharmacol. 118: 1377-1381, 1995.
282. SCHOEPP, D. D., JOHSON, B. G., SMITH, E. C. R., AND MCQUAID, L. A.: Stereo-selectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid. Mol. Pharmacol. 38: 222-228, 1990.
283. SENSE, A., LEBRUN, P., BLACHIER, F., AND MALAISSE, W. J.: Stimulus-secretion coupling of agmatine-induced insulin release: insulinotropic action of agmatine. Biochem. Pharmacol. 38: 327-330, 1989.
284. SHAPOVAL, L. N., SAGACH, V. F., AND POBEGAILO, L. S.: Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci. Lett. 132: 47-50, 1991.
285. SKOFITSCH, G., AND JACOBOWITZ, D. M.: Calcitonin gene-related peptide: detailed immunohistochemical distribution in the central nervous system. Peptides (Fayetteville) 6: 721-745, 1985.
286. SMITH, J. K., AND BARRON, K. W.: Cardiovascular effects of L-glutamate and tetrodotoxin microinjected into the rostral and caudal ventrolateral medulla in normotensive and spontaneously hypertensive rats. Brain Res. 506: 1-8, 1990a.
287. SMITH, J. K., AND BARRON, K. W.: GABAergic responses in ventrolateral medulla in spontaneously hypertensive rats. Am. J. Physiol. 258: R450-R456, 1990b.
288. SMITHIES, O., AND MAEDA, N.: Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension. Proc. Natl. Acad. Sci. USA 92: 5266-5272, 1995.
289. SNYDER, S. H.: Nitric oxide: first in a new class of neurotransmitters. Science (Wash. DC) 287: 494-496, 1992.
290. SPYER, K. M.: Annual Review Prize Lecture: Central nervous mechanisms contributing to cardiovascular control. J. Physiol. (Lend.) 474: 1-19, 1994.
291. SESOKO, S., MURATANI, H., TAKISHITA, S., TERUYA, H., KAWAZOE, N., AND FUKIYAMA, K: Modulation of baroreflex function by angiotensin II endogenous to the caudal ventrolateral medulla. Brain Res. 671: 38-44, 1995.
292. A receptor fonction in hippocampal cells is maintained by phosphorylation factors. Science (Wash. DC) 241: 339-341, 1988.
293. STITH, R. D., AND DORMER, K. J.: Pressor and endocrine responses to lesions of canine rostral ventrolateral medulla. Am. J. Physiol. 266: H2520-H2526, 1994.
294. 1 receptors in the cardiovascular response to hypothalamic defence area stimulation in the anesthetized rat. Br. J. Pharmacol. 117: 277-282, 1996.
295. STORNETTA, R. L., HUANGFU, D., ROSIN, D. L., LYNCH, K. R., AND GUYENET, P. G.: Alpha-2 adrenergic receptors: Immunohistochemical localization and role in mediating inhibition of adrenergic RVLM presympathetic neurons by catecholamines and clonidine. Ann. N. Y. Acad. Sci. 763: 541-551, 1995.
296. STORNETTA, R. L., NORTON, F. E., AND GUYENET, P. G.: Autonomie areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res. 624: 19-28, 1993.
297. STÖRS, B., ROTH, J., AND ZEISBERGER, E.: Thermoregulatory vasomotor reactions during endotoxin fever in guinea pigs. J. Therm. Biol. 20: 431-436, 1995.
298. 2-adrenoceptors modulating noradrenaline release? Eur. J. Pharmacol. 213: 305-307, 1992.
299. SULLIVAN, J. M., TRAYNELIS, S. F., CHEN, H. S., ESCOBAR, W., HEINBMANN, S. P., AND LIPTON, S. A.: Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron 13: 929-936, 1994.
300. SUN, M.-K: Medullospinal vasomotor neurones mediate hypotension from stimulation of prefrontal cortex. J. Auton. Nerv. Syst. 38: 209-218, 1992.
301. SUN, M.-K.: Central neural organization and control of sympathetic nervous system in mammals. Prog. Neurobiol. 47: 157-233, 1995.
302. SUN, M.-K., AND GUYENET, P. G.: GABA-mediated baroreceptor inhibition of reticulospinal neurons. Am. J. Physiol. 249: R672-R680, 1985.
303. SUN, M.-K., AND GUYENET, P. G.: Effect of clonidine and γ-aminobutyric acid on the discharges of medullospinal sympathoexdtatory neurons in the rat. Brain Res. 368: 1-17, 1986a.
304. SUN, M.-K., AND GUYENET, P. G.: Medullospinal sympathoexcitatory neurons in normotensive and spontaneously hypertensive rats. Am. J. Physiol. 250: R910-R917, 1986b.
305. SUN, M.-K., AND GUYENET, P. G.: Hypothalamic glutamatergic inputs to medullary aympathoexcitatory neurons in rats. Am. J. Physiol. 251: R798-R810, 1986c.
306. SUN, M.-K., AND GUYENET, P. G.: Arterial baroreceptor and vagal inputs to sympathoexcitatory neurons in rat medulla. Am. J. Physiol. 262: R699-R709, 1987.
307. SUN, M.-K., AND GUYENET, P. G.: Effects of vasopressin and other neuropeptides on rostral medullary sympathoexcitatory neurons in vitro. Brain Res. 492: 261-270, 1989.
308. SUN, M.-K., AND GUYENET, P. G.: Excitation of rostral medullary pacemaker neurons with putative sympathoexcitatory function by cyclic AMP and β-adrenoceptor agonists in vitro. Brain Res. 811: 30-40, 1990.
309. SUN, M.-K., HACKETT, J. T., AND GUYENET, P. G.: Sympathoexcitatory neurons of rostral ventrolateral medulla exhibit pacemaker properties in the presence of a glutamate receptor antagonist. Brain Res. 438: 23-40, 1988a.
310. SUN, M.-K., JESKE, I. T., AND REIS, D. J.: Cyanide excites medullary sympathoexcitatory neurons in rats. Am. J. Physiol. 262: R182-R189, 1992a.
311. SUN, M.-K., REGUNATHAN, S., AND REIS, D. J.: Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rats. Clin. Exp. Hypertens. 17(1&2): 115-128, 1995,
312. SUN, M.-K., AND REIS, D. J.: Effects of systemic ethanol on medullary vasomotor neurons and baroreflex. Neurosci. Lett. 137: 232-236, 1992.
313. + iontophoresis modifies responses to GABA and cyanide of reticulospinal vasomotor neurons in rats. Eur. J. Pharmacol. 236: 305-314, 1993a.
314. SUN, M.-K., AND REIS, D. J.: Hypoxic excitation of medullary vasomotor neurons in rats are not mediated by glutamate or nitric oxide. Neurosci. Lett. 157: 219-222, 1993b.
315. SUN, M.-K., AND REIS, O. J.: Differential responses of barosensitive neurons of rostral ventrolateral medulla to hypoxia in rats. Brain Res. 609: 333-337, 1993c.
316. SUN, M.-K., AND REIS, D. J.: Inhibition of protein kinase C differentially affects baroreflex inhibition and hypoxic excitation of medullary vasomotor neurons in rats. Brain Res. 636: 245-252, 1994a.
317. SUN, M.-K., AND REIS, D. J.: Central neural mechanisms mediating excitation of sympathetic neurons by hypoxia. Prog. Neurobiol. 44: 197-219, 1994b.
318. SUN, M.-K., AND REIS, D. J.: Intrathecal kynurenate but not benextramine blocks hypoxic sympatho-excitation in chemodenervated rats. J. Auton. Nerv. Syst. 47: 141-150, 1994c.
319. 2+ currents in pacemaker neurones of rat rostral ventro-lateral medulla in vitro. J. Physiol. (Lond.) 476: 101-116, 1994d.
320. SUN, M.-K., AND REIS, D. J.: Hypoxia selectively excites vasomotor neurons of rostral ventrolateral medulla in rats. Am. J. Physiol. 266: R245-R256, 1994e.
321. SUN, M.-K., AND REIS, D. J.: NMDA receptor mediated sympathetic chemoreflex excitation of RVL-spinal vasomotor neurons in rats. J. Physiol. (Lond.) 482: 53-68, 1995a.
322. SUN, M.-K., AND REIS, D. J.: GABA-mediated inhibition of pacemaker neurons of rostral ventrolateral medulla by clonidine in vitro. Eur. J. Pharmacol. 276: 291-296, 1995b.
323. SUN, M.-K., AND REIS, D. J.: Urethane directly inhibits chemoreflex excitation of medullary vasomotor neurons in rats. Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. Sect. 293: 237-243, 1995c.
324. SUN, M.-K., AND REIS, D. J.: Decerebration does not alter hypoxic sympatho-excitatory responses in rats. J, Auton. Nerv. Syst. 53: 77-81, 1995d.
325. SUN, M.-K., AND REIS, D. J.: Medullary vasomotor activity and hypoxic sympathoexcitation in pentobarbital-anesthetized rats. Am. J. Physiol. 270: R348-R355, 1996a.
326. SUN, M.-K., AND REIS, D. J.: Intracisternal administration of angiotensin II does not excite reticulospinal vasomotor neurons in anesthetized rats. Eur. J. Pharmacol. 304: 63-71, 1996b.
327. SUN, M.-K., AND REIS, D. J.: Ethanol inhibits chemoreflex excitation of reticulospinal vasomotor neurons. Brain Res. in press: 1996c.
328. SUN, M.-K., AND REIS, D. J.: Excitatory amino acid-mediated chemoreflex excitation of respiratory neurones in rostral ventrolateral medulla in rats. J. Physiol. (Lond.) 492: 559-571, 1996d.
329. SUN, M.-K., AND SPYER, K. M.: GABA-mediated inhibition of medullary vasomotor neurones by area postrema stimulation in rats. J. Physiol. (Lond.) 436: 669-684, 1991a.
330. SUN, M.-K., AND SPYER, K M.: Nociceptive inputs onto RVL-spinal vasomotor neurones in rats. J. Physiol. (Lond.) 436: 685-700, 1991b.
331. SUN, M.-K., AND SPYER, K M.: Reticulospinal vasomotor neurones in decerebrate rats: effect of pentobarbitone. J. Auton. Nerv. Syst. 33: 85-90, 1991c.
332. SUN, M.-K., AND SPYER, K. M.: Responses of RVL-spinal vasomotor neurones to chemo-receptor stimulation in rats. J. Auton. Nerv. Syst. 33: 79-84, 1991d.
333. SUN, M.-K., STORNETTA, R. L., AND GUYENET, P. G.: Morphology of rostral medullary neurons with intrinsic pacemaker activity in the rat. Brain Res. 556: 61-70, 1991.
334. SUN, M.-K, WAHLESTEDT, C., AND REIS, D. J.: Inositohexakisphosphate (IP6) excites medullary sympatho-excitatory neurons in rats. Eur. J. Pharmacol. 215: 9-16, 1992b.
335. SUN, M.-K., WAHLESTEDT, C., AND REIS, D. J.: Action of externally applied ATP on rat reticulospinal vasomotor neurons. Eur. J. Pharmacol. 224: 93-96, 1992c.
336. SUN, M.-K., YOUNG, B. S., HACKETT, J. T., AND GUYENET, P. G.: Reticulospinal pacemaker neurons of the rostral ventrolateral medulla with putative sympathoexcitatory function: an intracellular study in vitro. Brain Res. 442: 229-239, 1988b.
337. SUN, M.-K., YOUNG, B. S., HACKETT, J. T., AND GUYENET, P. G.: Rostral ventrolateral medullary neurons with intrinsic pacemaker properties are not catecholaminergic. Brain Res. 451: 345-449, 1988c.
338. SUN, X. P., AND STANLEY, E. F.: An ATP-activated, ligand-gated ion channel on cholinergic presynaptic nerve terminal. Proc. Natl. Acad. Sci. USA 93: 1859-1863, 1996.
339. 2 muscarinic receptors mediate pressor responses to cholinergic agonists in the ventrolateral medullary pressor area. Brain Res. 449: 141-149, 1988.
340. SUNDARAM, K., AND SAPRU, H.: Cholinergic nerve terminals in the ventrolateral medullary pressor area: pharmacological evidence. J. Auton. Nerv. Syst. 22: 221-228, 1988.
341. SUZDAK, P. D., GLOWA, J. R., CRAWLEY, J. N., SCHWARTZ, R. D., SKOLNICK, P., AND PAUL, S. M: A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science (Wash. DC) 234: 1243-1247, 1986.
342. SWANSON, L. W., SIMMONS, S. M., WHITING, P. J., AND LINDSTROM, J.: Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system. J. Neurosci. 7: 3334-3342, 1987.
343. SZABO, B., AND URBAN, R.: Mechanism of sympathoinhibition by imidazolines. Ann. N. Y. Acad. Sci. 763: 552-565, 1995.
344. SZABO, B., URBAN, R., LIMBERGER, N., AND STARKE, N.: Cardiovascular effects of agmatine, a "clonidine-displacing substance", in conscious rabbits. Naunyn-Schmiedebergs Arch. Pharmacol. 351: 268-273, 1995.
345. 2-adrenoceptors. Naunyn-Schmiedeberg's Arch. of Pharmacol. 348: 593-600, 1993.
346. TABOR, C. W., AND TABOR, H.: Polyamines. Annu. Rev. Biochem. 53: 749-790, 1984.
347. TAKAYAMA, K., AND MIURA, M.: Glutamate-immunoreactive neurons of the central amygdaloid nucleus projecting to the subretrofacial nucleus of SHR and WKY rats-A double-labeling study. Neurosci. Lett. 134: 62-66, 1991.
348. TAKAYAMA, K., AND MIURA, M.: Differences in distribution of glutamate-immunoreactive neurons projecting into the subretrofacial nucleus in the rostral ventrolateral medulla of SHR and WKY: a double-labelling study. Brain Res. 570: 259-266, 1992.
349. TAKEDA, K., AND BUNAG, R. D.: Chronic propranolol treatment inhibits sympathetic nerve activity and keeps pressure from rising in spontaneously hypertensive rats. Hypertension 2: 228-235, 1980.
350. TANAKA, M., MATSUMOTO, Y., MURAKAMI, T., HISA, Y., AND IDATA, Y.: The origin of catecholaminergic innervation in the rostral ventromedial medulla oblongata of the rat. Neurosci. Lett. 207: 53-56, 1996.
351. TESSON, F., PRIP-BUUS, C., LEMOINES, A., PEGORIER, J.-P., AND PARINI, A.: Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver: major localization to the mitochondrial outer membrane. J. Biol. Chem. 260: 155-160, 1991.
352. 2-imidazoline binding sites on monoamine oxidase. J. Biol. Chem. 270: 9856-9861, 1995.
353. TIBIRICA, E., FELDMAN, J., AND BOUSQUEST, P.: Differences in the ability of yohimbine to antagonize the hypotensive effect of clonidine in normotensive and spontaneously hypertensive anaesthetized rats. J. Pharmacol. Exp. Ther. 244: 1062-1066, 1988.
354. TIBIRICA, E., FELDMAN, J., AND BOUSQUEST, P.: Contribution of catecholaminergic neurons of the dorsomedial and ventrolateral medulla-oblongata to the hypotensive effect of clonidine in spontaneously hypertensive rats: in vivo voltammetric studies. J. Hypertens. 10: 1327-1334, 1992.
355. TIBIRICA, E., FELDMAN, J., MERMET, C., GONON, F., AND BOUSQUET, P.: An imidazoline-specific mechanism for the hypotensive effect of clonidine: A study with yohimbine and idazoxan. J. Pharmacol. Exp. Ther. 256: 606-613, 1991a.
356. TIBIRICA, E., FELDMAN, J., MERMET, C., MONASSIER, L., GONON, F., AND BOUSQUET, P.: Selectivity of rilmenidine for the nucleus reticularis, a ventrolateral medullary structure containing imidazoline-preferring receptors. Eur. J. Pharmacol. 209: 213-221, 1991b.
357. 2-Adrenoceptors: classification, localization, mechanisms and target for drugs. J. Med. Chem. 25: 1389-1401, 1982.
358. TIMMERMANS, P. B. M. W. M., WONG, P. C., CHIU, A. T., HERBLIN, W. F., BENFIELD, P., CARINI, D. J., LEE, H. J., WEXLER, R. R., SAYE, J. A M., AND SMITH, R. D.: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45: 205-251, 1993.
359. TINGLEY, F. D. II. I., AND ARENIĆ, S. T.: Evidence for clonidine presynaptically modulating amino acid release in the rostral ventral medulla: role in hypertension. Brain Res. 537: 175-181, 1990.
360. TISON, F., MONS, N., ROUET-KARAMA, S., GEFFARD, M., AND HENRY, P.: Endogenous L-DOPA in the rat dorsal vagal complex: an immunocytochemical study by light and electron microscopy. Brain Res. 497: 260-270, 1989.
361. TIZZANO, J. P., GRIFFEY, K. I., JOHNSON, J. A., FIX, A. S., HELTON, D. R., AND SCHOEPP, D. D.: Intracerebral 1S,3S-1-aminocyclopentane-1,3-dicarboxylic acid (1S, 3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor agonists. Neurosci. Lett. 162: 12-16, 1993.
362. TOGASHI, H., SAKUMA, I., YOSHIOKA, M., KOBAYASHI, T., YASUDA, H., KITABATAKE, A., SAITO, H., GROSS, S. S., AND LEVI, R.: A central nervous system action of nitric oxide in blood pressure regulation. J. Pharmacol. Exp. Ther. 262: 343-347, 1992.
363. TRZEBSKI, A., AND BARADZIEJ, S.: Role of the rostral ventrolateral medulla in the generation of synchronized sympathetic rhythmicities in the rat. J. Auton. Nerv. Syst. 41: 129-140, 1992.
364. TSENG, C.-J., MOSQUEDA-GARCIA, R., APPALSAMY, M., AND ROBERTSON, D.: Cardiovascular effects of neuropeptide Y in rat brainstem nuclei. Circ. Res. 64: 55-61, 1988.
365. TSUCHIHASHI, T., ABE, I., AND FUJISHIMA, M.: Role of metabotropic glutamate receptors in ventrolateral medulla of hypertensive rats. Hypertension 24: 648-652, 1994.
366. TSUCHIHASHI, T., AND AVERILL, D. B.: Metabotropic glutamate receptors in the ventrolateral medulla of rats. Hypertension 21: 739-744, 1993.
367. UNDERWOOD, M. D., IADECOLA, C., AND REIS, D. J.: Lesions of the rostral ventrolateral medulla reduce the cerebrovascular response to hypoxia. Brain Res. 635: 217-223, 1994.
368. 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomical correlates of the pharmacological effects of clonidine and related adrenergic agents. Brain Res. Rev. 7: 69-101, 1984.
369. 2-adrenoceptors or imidazoline receptors? J. Pharmacol. Exp. Ther. 270: 572-678, 1994.
370. URBANSKI, R. W. MURUGAIAN, J., KRIEGER, A. J., AND SAPRU, H. N.: Cardiovascular effects of substance P receptor stimulation in the ventrolateral medullary pressor and depressor areas. Brain Res. 491: 383-389, 1989.
371. URBANSKI, R. W., AND SAPRU, H. N.: Putative neurotransmitters involved in medullary cardiovascular control. J. Auton. Nerv. Syst. 25: 181-193, 1988.
372. A receptors. Mol. Brain Res. 31: 165-172, 1995.
373. VAN DEN BUSSE, M., AND ITOH, S.: Central effects of endothelin on baroreflex of spontaneously hypertensive rats. J. Hypertens. 11: 379-387, 1993.
374. VANNI-MERCIER, G., SAKAI, K., LIN, J. S., AND JOUVET, M.: Mapping of cholinoceptive brainstem structures responsible for the generation of paradoxical sleep in the cat. Arch. Ital. Biol. 127: 133-164, 1989.
375. VARGA, K., GANTENBERG, N. S., AND KUNOS, G.: Endogenous γ-aminobutyric acid (GABA) mediates ethanol inhibition of vagally mediated reflex bradycardia elicited from aortic barorsceptors. J. Pharmacol. Exp. Ther. 268: 1057-1062, 1994.
376. VERBERNE, A. J. M.: Medullary sympathoexcitatory neurons are inhibited by activation of the medial prefrontal cortex in the rat. Am. J. Physiol. 270: R713-R719, 1996.
377. A receptor function in the early period after transient forebrain ischaemia in the rat. Eur. J. Neurosci. 5: 955-960, 1993.
378. B receptors. Proc. Natl. Acad. Sci. USA 93: 5049-5054, 1996.
379. WANG, H., REGUNATHAN, S., MEELEY, M. P., AND REIS, D. J.: Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin celle. Mol. Pharmacol. 42: 792-801, 1992.
380. WANG, L., MILNE, B., AND JHAMANDAS, K.: Involvement of excitatory amino acid pathways in the expression of precipitated opioid withdrawal in the rostral ventrolateral medulla: an in vivo voltammetric study. Brain Res. 697: 130-142, 1995.
381. WANG, W., HAN, H.-Y., AND ZUCKER, I. H.: Depressed baroreflex in heart failure is not due to structural change in carotid sinus nerve fibers. J. Auton. Nerv. Syst. 57: 101-108, 1996.
382. WANG, Y.-X., AND PANG, C. C.: Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase, J. Pharmacol. Exp. Ther. 265: 263-272, 1993.
383. WEITZEL, G., PFEIFFER, B., AND STOCK, W.: Insulin-like partial effects of agmatine derivatives in adipocytes. Hoppe Seylers. Z. Physiol. Chem. 361: 51-60, 1980.
384. WHITE, P. J., HOPE, W., AND ROSE'MEYER, R. B.: The role of adenosine in the hypotensive actions of morphine. Eur. J. Pharmacol. 286: 315-319, 1995.
385. WILLETTE, R. N., BARCAS, P. P., KRIEGER, A. J., AND SAPRU, H. N.: Endogenous GABAergic mechanisms in the medulla and the regulation of blood pressure. J. Pharmacol. Exp. Ther. 230: 34-39, 1984a.
386. WILLETTE, R. N., KRIEGER, A. J., BARCAS, P. P., AND SAPRU, H. N.: Medullary γ-aminobutyric acid (GABA) receptors and the regulation of blood pressure in the rat. J. Pharmacol. Exp. Ther. 226: 893-899, 1983.
387. WILLETTE, R. N., PUNNEN, S., KRIEGER, A. J., AND SAPRU, H. N.: Cardiovascular control by cholinergic mechanisms in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther. 231: 457-463, 1984b.
388. WILSON, C. G., AND BONHAM, A. C.: Area postrema excites and inhibits sympathetic-related neurons in rostral ventrolateral medulla in rabbit. Am. J. Physiol. 266: H1075-H1086, 1994.
389. WINN, H. R., RUBIO, R., AND BERNE, R. M.: Brain adenosine concentration during hypoxia in rats. Am. J. Physiol. 241: H235-H242, 1981.
390. WONG, P. C., CHIU, A. T., PRICE, W. A., THOOLEN, M. J. M. C., CARINI, D. J., JOHNSON, A. L., TABER, R. I., AND TIMMERMANS, P. B. M. W. M.: Nonpeptide angiotensin II receptor antagonists: I-Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl) imidazole-5-acetic acid, sodium salt (S-8307). J. Pharmacol. Exp. Ther. 247: 1-7, 1988.
391. WRIGHT, J. W., AND HARDING, J. W.: Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci. Biobehav. Rev. 18: 21-53, 1994.
392. XIAO, Y., AND ZHOU, Z. N.: Role of central vasopressin in the maintenance of cardiovascular activities during acute hypoxia. Acta Physiologica Sinica 45: 423-430, 1993.
393. Xu T., WANG, T., AND HAN, J.-S.: Centrally acting endogenous hypotensive substances in rats subjected to endotoxic shock. Life Sci. 51: 1817-1821, 1992.
394. YAMADA, K. A., MCALLEN, R. M., AND LOEWY, A. D.: GABA antagonists applied to the ventral surface of the medulla oblongata block the baroreceptor reflex. Brain Res. 297: 175-180, 1984.
395. YAMAZOE, M., SHIOSAKA, S., EMSON, P. C., AND TOHYAMA, M.: Distribution of neuropeptide Y in the lower brainstem: an immunohistochemical analysis. Brain Res. 335: 109-120, 1985.
396. YAN, J., CHEN, H., LIAO, W., AND Lu, S.: Cardiovascular effects of thyrotropin-releasing hormone in nor-motensive and hypotensive rats: role of rostral ventrolateral medulla. Circ. Shock 37: 253-261, 1992.
397. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K., AND MASAKI, T.: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
398. YANG, T. L.-C., CHAI, C. Y., AND YEN, C.-T.: Enhanced sympathetic reactivity to glutamate stimulation in medulla oblongata of spontaneously hypertensive rats. Am. J. Physiol. 268: H1499-H1509, 1995.
399. YANG, Z., CHAN, Y. S., AND WONG, T. M.: Effects of kainic acid administered to the caudal ventrolateral medulla on arterial blood pressure in the spontaneously hypertensive and normotensive Wistar-Kyoto rats. Neurosci. Lett. 202: 145-148, 1996.
400. YUE, J.-L., GOSHIMA, Y., MIYAMAE, T., AND MISU, Y.: Evidence for L-DOPA relevant to modulation of sympathetic activity in the rostral ventrolateral medulla of rats. Brain Res. 629: 310-314, 1993.
401. YUE, J.-L., OKUMURA, Y., MIYAMAE, T., UEDA, H., AND MISU, Y.: Altered tonic L-3,4-dihydroxyphenyl-alanine system in the nucleus tractus solitarii and the rostral ventroalteral medulla of spontaneously hypertensive rats. Neuroscience 67: 95-106, 1995.
402. ZANCHI, A., SCHAAD,. C., OSTERHELD, M.-C., GROUZMANN, E., NUSSBERGER, J., BRUNNER, H. R., AND WAEBER, B.: Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. Am. J. Physiol. 268: H2267-H2273, 1995.
403. ZANZINGER, J., CZACHURSKI, J., AND SELLER, H.: Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ. Res. 75: 1073-1077, 1994.
404. ZANZINGER, J., CZACHURSKI, J., AND SELLER, H.: Inhibition of basal and reflexmediated sympathetic activity in the RVLM by nitric oxide. Am. J. Physiol. 268: R958-R962, 1995a.
405. ZANZINGER, J., CZACHURSKI, J., AND SELLER, H.: Effects of nitric oxide on sympathetic baroreflex transmission in the nucleus tractus solitarii and caudal ventrolateral medulla in cats. Neurosci. Lett. 197: 199-202, 1995b.
406. ZHONG, S., HUANG, Z.-S., GEBBER, G. L., AND BARMAN, S. M.: The 10-Hz sympathetic rhythm is dependent on raphe and rostral ventrolateral medullary neurons. Am. J. Physiol. 264: R857-R866, 1993.
407. ZIEGLGANSBERGER, W., AND TULLOCH, I. F.: The effects of methionine- and leucine-enkephalin on spinal neurons of the cat. Brain Res. 167: 53-64, 1979.
408. ZUCKER, I. H., WANG, W., BRÄNDLE, M., SCHULTZ, H. D., AND PATEL, K. P.: Neural regulation of sympathetic nerve activity in heart failure. Prog. Cardiovaec. Dis. 37: 397-414, 1995.